Alphα-synuclein overexpression increases phospho-protein phosphatase 2A levels via formation of calmodulin/Src complex

Neurochemistry International

Volumn 63, Issue 3, 2013, Pages 180-194

  Yang, W ^a   Wang, X ^a   Duan, C ^a   Lu, L ^a   Yang, H ^a  

^a BEIJING INSTITUTE FOR BRAIN DISORDERS   (China)

Author keywords

Alph synuclein ( Syn); Parkinson's disease (PD); Protein phosphatase 2A (PP2A); Src kinase

Indexed keywords

ALPHA SYNUCLEIN; CALMODULIN; PHOSPHOPROTEIN PHOSPHATASE 2A; PROTEIN TYROSINE KINASE; PHOSPHOPROTEIN PHOSPHATASE 2; PRIMER DNA; SRC KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CELL VIABILITY; COMPLEX FORMATION; CONTROLLED STUDY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MALE; MOUSE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; METABOLISM; NUCLEOTIDE SEQUENCE; PHOSPHORYLATION; SPRAGUE DAWLEY RAT; TRANSGENIC MOUSE; TUMOR CELL LINE; ALPHA-SYNUCLEIN (Α-SYN); DRUG ANTAGONISM; PARKINSON'S DISEASE (PD); PROTEIN PHOSPHATASE 2A (PP2A);

MUS MUSCULUS;

ALPHA-SYNUCLEIN; ANIMALS; BASE SEQUENCE; CALMODULIN; CELL LINE, TUMOR; DNA PRIMERS; HUMANS; IN SITU NICK-END LABELING; MICE; MICE, TRANSGENIC; PHOSPHORYLATION; PROTEIN PHOSPHATASE 2; RATS; RATS, SPRAGUE-DAWLEY; SRC-FAMILY KINASES;

ALPHA-SYNUCLEIN (Α-SYN); PARKINSON'S DISEASE (PD); PROTEIN PHOSPHATASE 2A (PP2A); SRC KINASE;

EID: 84880184556     PISSN: 01970186     EISSN: 18729754     Source Type: Journal    
DOI: 10.1016/j.neuint.2013.06.010     Document Type: Article

References (42)

1. Barisic, S., Schmidt, C., Walczak, H., Kulms, D., 2010. Tyrosine phosphatase inhibition triggers sustained canonical serine-dependent NFkappaB activation via Src-dependent blockade of PP2A. Biochem. Pharmacol. 80, 439-447.
2. Braak, H., Bohl, J.R., Muller, C.M., Rub, U., de Vos, R.A., Del, T.K., 2006. Stanley Fahn Lecture 2005: the staging procedure for the inclusion body pathology associated with sporadic Parkinson's disease reconsidered. Mov. Disord. 21, 2042-2051. (Pubitemid 46140410)
3. Butler, E.K., Voigt, A., Lutz, A.K., Toegel, J.P., Gerhardt, E., Karsten, P., Falkenburger, B., Reinartz, A., Winklhofer, K.F., Schulz, J.B., 2012. The mitochondrial chaperone protein TRAP1 mitigates alpha-synuclein toxicity. PloS Genet. http://dx.doi.org/10.1371/journal.pgen.1002488.
4. Cali, T., Ottolini, D., Negro, A., Brini, M., 2012. Alpha-synuclein controls mitochondrial calcium homeostasis by enhancing endoplasmic reticulummitochondria interactions. J. Biol. Chem. 287, 17914-17929.
5. Chan, T., Chow, A.M., Cheng, X.R., Tang, D.W., Brown, I.R., Kerman, K., 2012. Oxidative stress effect of dopamine on alpha-synuclein: electroanalysis of solvent interactions. ACS Chem. Neurosci. 3, 569-574.
6. Chen, J., Martin, B.L., Brautigan, D.L., 1992. Regulation of protein serine-threonine phosphatase type-2A by tyrosine phosphorylation. Science 257, 1261-1264.
7. Chen, J., Parsons, S., Brautigan, D.L., 1994. Tyrosine phosphorylation of protein phosphatase 2A in response to growth stimulation and v-src transformation of fibroblasts. J. Biol. Chem. 269, 7957-7962. (Pubitemid 24200196)
8. Chinta, S.J., Mallajosyula, J.K., Rane, A., Andersen, J.K., 2010. Mitochondrial alphasynuclein accumulation impairs complex I function in dopaminergic neurons and results in increased mitophagy in vivo. Neurosci. Lett. 486, 235-239.
9. Clayton, D.F., George, J.M., 1998. The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease. Trends Neurosci. 21, 249-254. (Pubitemid 28239982)
10. Devi, L., Anandatheerthavarada, H.K., 2010. Mitochondrial trafficking of APP and alpha synuclein: relevance to mitochondrial dysfunction in Alzheimer's and Parkinson's diseases. Biochim. Biophys. Acta 1802, 11-19.
11. Devi, L., Raghavendran, V., Prabhu, B.M., Avadhani, N.G., Anandatheerthavarada, H.K., 2008. Mitochondrial import and accumulation of alpha-synuclein impair complex I in human dopaminergic neuronal cultures and Parkinson disease brain. J. Biol. Chem. 283, 9089-9100.
12. Fedida-Metula, S., Feldman, B., Koshelev, V., Levin-Gromiko, U., Voronov, E., Fishman, D., 2012. Lipid rafts couple store-operated Ca2+ entry to constitutive activation of PKB/Akt in a Ca2+/calmodulin-, Src- and PP2A-mediated pathway and promote melanoma tumor growth. Carcinogenesis 33, 740-750.
13. Follett, J., Darlow, B., Wong, M.B., Goodwin, J., Pountney, D.L., 2013. Potassium depolarization and raised calcium induces alpha-synuclein aggregates. Neurotox. Res. 23, 378-392.
14. Furukawa, K., Matsuzaki-Kobayashi, M., Hasegawa, T., Kikuchi, A., Sugeno, N., Itoyama, Y., Wang, Y., Yao, P.J., Bushlin, I., Takeda, A., 2006. Plasma membrane ion permeability induced by mutant alpha-synuclein contributes to the degeneration of neural cells. J. Neurochem. 97, 1071-1077.
15. Goodwin, J., Nath, S., Engelborghs, Y., Pountney, D.L., 2012. Raised calcium and oxidative stress cooperatively promote alpha-synuclein aggregate formation. Neurochem. Int. http://dx.doi.org/10.1016/j. neuint. 2012. 11.004.
16. Gui, Y., Wang, X., Kang, W., Zhang, Y., Zhang, Y., Zhou, Y., Quinn, T., Liu, J., Chen, S., 2012. Extracellular signal-regulated kinase is involved in alpha-synucleininduced mitochondrial dynamic disorders by regulating dynamin-like protein 1. Neurobiol. Aging 33, 2841-2854.
17. Hossain, M.I., Kamaruddin, M.A., Cheng, H., 2012. Aberrant regulation and function of Src family tyrosine kinases: their potential contributions to glutamateinduced neurotoxicity. Clin. Exp. Pharmacol. Physiol. 39, 684-691.
18. Houlden, H., Singleton, A.B., 2012. The genetics and neuropathology of Parkinson's disease. Acta Neuropathol. 124, 325-338.
19. Jiang, J., Yang, W., Huang, P., Bu, X., Zhang, N., Li, J., 2009. Increased phosphorylation of Ets-like transcription factor-1 in neurons of hypoxic preconditioned mice. Neurochem. Res. 34, 1443-1450.
20. Kar, S., Palit, S., Ball, W.B., Das, P.K., 2012. Carnosic acid modulates Akt/IKK/NFkappaB signaling by PP2A and induces intrinsic and extrinsic pathway mediated apoptosis in human prostate carcinoma PC-3 cells. Apoptosis 17, 735-747.
21. Maroteaux, L., Campanelli, J.T., Scheller, R.H., 1988. Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal. J. Neurosci. 8, 2804-2815.
22. Lastres-Becker, I., Ulusoy, A., Innamorato, N.G., Sahin, G., Rabano, A., Kirik, D., Cuadrado, A., 2012. Alpha-synuclein expression and Nrf2 deficiency cooperate to aggravate protein aggregation, neuronal death and inflammation in earlystage Parkinson's disease. Hum. Mol. Genet. 21, 3173-3192.
23. Lee, K.W., Chen, W., Junn, E., Im, J.Y., Grosso, H., Sonsalla, P.K., Feng, X., Ray, N., Fernandez, J.R., Chao, Y., Masliah, E., Voronkov, M., Braithwaite, S.P., Stock, J.B., Mouradian, M.M., 2011. Enhanced phosphatase activity attenuates alphasynucleinopathy in a mouse model. J. Neurosci. 31, 6963-6971.
24. Lou, H., Montoya, S.E., Alerte, T.N., Wang, J., Wu, J., Peng, X., Hong, C.S., Friedrich, E.E., Mader, S.A., Pedersen, C.J., Marcus, B.S., McCormack, A.L., Di Monte, D.A., Daubner, S.C., Perez, R.G., 2010. Serine 129 phosphorylation reduces the ability of alpha-synuclein to regulate tyrosine hydroxylase and protein phosphatase 2A in vitro and in vivo. J. Biol. Chem. 285, 17648-17661.
25. Majd, S., Chegini, F., Chataway, T., Zhou, X.F., Gai, W., 2012. Reciprocal Induction Between alpha-synuclein and beta-Amyloid in Adult Rat Neurons. Neurotox. Res. 23, 69-78.
26. Mitra, A., Menezes, M.E., Pannell, L.K., Mulekar, M.S., Honkanen, R.E., Shevde, L.A., Samant, R.S., 2012. DNAJB6 chaperones PP2A mediated dephosphorylation of GSK3beta to downregulate beta-catenin transcription target, osteopontin. Oncogene 31, 4472-4483.
27. Napolitano, M., Picconi, B., Centonze, D., Bernardi, G., Calabresi, P., Gulino, A., 2006. L-DOPA treatment of parkinsonian rats changes the expression of Src, Lyn and PKC kinases. Neurosci. Lett. 398, 211-214. (Pubitemid 43673714)
28. Nath, S., Goodwin, J., Engelborghs, Y., Pountney, D.L., 2011. Raised calcium promotes alpha-synuclein aggregate formation. Mol. Cell. Neurosci. 46, 516-526.
29. Pacheco, C., Aguayo, L.G., Opazo, C., 2012. An extracellular mechanism that can explain the neurotoxic effects of alpha-synuclein aggregates in the brain. Front. Physiol. 3, 297.
30. Peng, X., Tehranian, R., Dietrich, P., Stefanis, L., Perez, R.G., 2005. Alpha-synuclein activation of protein phosphatase 2A reduces tyrosine hydroxylase phosphorylation in dopaminergic cells. J. Cell Sci. 118, 3523-3530. (Pubitemid 41246105)
31. Pitre, A., Davis, N., Paul, M., Orr, A.W., Skalli, O., 2012. Synemin promotes AKTdependent glioblastoma cell proliferation by antagonizing PP2A. Mol. Biol. Cell 23, 1243-1253.
32. Qi, Z., Yang, W., Liu, Y., Cui, T., Gao, H., Duan, C., Lu, L., Zhao, C., Zhao, H., Yang, H., 2011. Loss of PINK1 function decreases PP2A activity and promotes autophagy in dopaminergic cells and a murine model. Neurochem. Int. 59, 572-581.
33. Reznichenko, L., Cheng, Q., Nizar, K., Gratiy, S.L., Saisan, P.A., Rockenstein, E.M., Gonzalez, T., Patrick, C., Spencer, B., Desplats, P., Dale, A.M., Devor, A., Masliah, E., 2012. In vivo alterations in calcium buffering capacity in transgenic mouse model of synucleinopathy. J. Neurosci. 32, 9992-9998.
34. Siddiqui, A., Chinta, S.J., Mallajosyula, J.K., Rajagopolan, S., Hanson, I., Rane, A., Melov, S., Andersen, J.K., 2012. Selective binding of nuclear alpha-synuclein to the PGC1alpha promoter under conditions of oxidative stress may contribute to losses in mitochondrial function: implications for Parkinson's disease. Free Radic. Biol. Med. 53, 993-1003.
35. van Rooijen, B.D., Claessens, M.M., Subramaniam, V., 2010. Membrane permeabilization by oligomeric alpha-synuclein: in search of the mechanism. PLoS One 5, e14292.
36. Venderova, K., Park, D.S., 2012. Programmed cell death in Parkinson's disease. Cold Spring Harb. Perspect. Med. http://dx.doi.org/10.1101/cshperspect. a009365.
37. Wan, O.W., Chung, K.K., 2012. The role of alpha-synuclein oligomerization and aggregation in cellular and animal models of Parkinson's disease. PLoS One 7, e38545.
38. Williams, G.C., Liu, A., Knipp, G., Sinko, P.J., 2002. Direct evidence that saquinavir is transported by multidrug resistance-associated protein (MRP1) and canalicular multispecific organic anion transporter (MRP2). Antimicrob. Agents Chemother. 46, 3456-3462. (Pubitemid 35192911)
39. Wu, F., Poon, W.S., Lu, G., Wang, A., Meng, H., Feng, L., Li, Z., Liu, S., 2009. Alphasynuclein knockdown attenuates MPP+ induced mitochondrial dysfunction of SH-SY5Y cells. Brain Res. 1292, 173-179.
40. Wu, J., Lou, H., Alerte, T.M., Stachowski, E.K., Chen, J., Singleton, A.B., Hamilton, R.L., Perez, R.G., 2012. Lewy-like aggregation of alpha-synuclein reduces protein phosphatase 2A activity in vitro and in vivo. Neuroscience 207, 288-297.
41. Ying, Z., Lin, F., Gu, W., Su, Y., Arshad, A., Qing, H., Deng, Y., 2011. Alpha-synuclein increases U251 cells vulnerability to hydrogen peroxide by disrupting calcium homeostasis. J. Neural. Transm. 118, 1165-1172.
42. Zhu, Y., Duan, C., Lu, L., Gao, H., Zhao, C., Yu, S., Ueda, K., Chan, P., Yang, H., 2011. Alpha-synuclein overexpression impairs mitochondrial function by associating with adenylate translocator. Int. J. Biochem. Cell Biol. 43, 732-741.